Polen Capital Management Reduces $94M in Intuitive Surgical, Inc. ($ISRG)

Key Points

  • Polen Capital Management changed its Intuitive Surgical, Inc. ($ISRG) stake by 27.98% last quarter, cutting to 606,826 shares worth $241.32 million.
  • Wall Street's consensus rating on $ISRG is Buy and an average price target of $478.01.
  • $ISRG last traded around $397.68.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Polen Capital Management reduced its position in Intuitive Surgical, Inc. ($ISRG) by 27.98% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 606,826 shares of Intuitive Surgical, Inc. after selling 235,792 shares during the quarter. Polen Capital Management's holdings in Intuitive Surgical, Inc. were worth $241.32 million as of its most recent filing.

Intuitive Surgical, Inc. Stock Up 6.7%

Shares of Intuitive Surgical, Inc. ($ISRG) traded around $397.68 on Saturday, up 6.7% for the day.

Last price$397.68
Market cap$135.02B
P/E ratio42.73
Forward P/E31.22
PEG ratio1.80
Beta1.46
52-week low$328.57
52-week high$603.88
50-day MA$383.61
200-day MA$467.59
Current ratio4.96
Quick ratio3.64

Intuitive Surgical, Inc. Earnings

EPS (ttm)$8.82
Revenue (ttm)$11.03B
Revenue growth18.50%
Net margin28.45%
Return on equity17.42%
Next earningsOct 20, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$478.01
High target$685
Low target$324
Analysts covering30

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

ExchangeNasdaqGS
SectorHealthcare
IndustryMedical Instruments & Supplies
HeadquartersSunnyvale, CA
CEOMr. David J. Rosa
Employees17,021

Get Intuitive Surgical, Inc. alerts

New 13F filings, insider trades, and analyst moves on $ISRG, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.